Christopher G R Perry
Overview
Explore the profile of Christopher G R Perry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
80
Citations
1364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Delfinis L, Khajehzadehshoushtar S, Flewwelling L, Andrews N, Garibotti M, Gandhi S, et al.
bioRxiv
. 2024 Nov;
PMID: 39484418
Cancer cachexia, and the related loss of muscle and strength, worsens quality of life and lowers overall survival. Recently, a novel 'pre-atrophy' muscle weakness was identified during early-stage cancer. While...
2.
Tsitkanou S, Morena da Silva F, Cabrera A, Schrems E, Muhyudin R, Koopmans P, et al.
Am J Physiol Cell Physiol
. 2024 Sep;
327(5):C1308-C1322.
PMID: 39344417
Mitochondrial dysfunction is a hallmark of cancer cachexia (CC). Mitochondrial reactive oxygen species (ROS) are elevated in muscle shortly after tumor onset. Targeting mitochondrial ROS may be a viable option...
3.
Gandhi S, Sweeney G, Perry C
Biomedicines
. 2024 Jul;
12(7).
PMID: 39061981
Duchenne muscular dystrophy (DMD) is caused by genetic mutations in the cytoskeletal-sarcolemmal anchor protein dystrophin. Repeated cycles of sarcolemmal tearing and repair lead to a variety of secondary cellular and...
4.
Gandhi S, Sweeney H, Hart C, Han R, Perry C
Cells
. 2024 Jul;
13(14.
PMID: 39056750
Duchenne muscular dystrophy (DMD) is a progressive neuromuscular disease caused by mutations to the dystrophin gene, resulting in deficiency of dystrophin protein, loss of myofiber integrity in skeletal and cardiac...
5.
Ogilvie L, Delfinis L, Coyle-Asbil B, Vudatha V, Alshamali R, Garlisi B, et al.
Am J Pathol
. 2024 Jul;
194(10):1823-1843.
PMID: 39032600
Muscle atrophy and weakness are prevalent features of cancer. Although extensive research has characterized skeletal muscle wasting in cancer cachexia, limited studies have investigated how cardiac structure and function are...
6.
Gottlieb D, Abushamat L, Nadeau K, Regensteiner J, Reusch J, Tommerdahl K, et al.
J Diabetes Complications
. 2024 Jul;
38(8):108798.
PMID: 38991492
Aims: Type 1 diabetes has been associated with mitochondrial dysfunction. However, the mechanism of this dysfunction in adults remains unclear. Methods: A secondary analysis was conducted using data from several...
7.
Delfinis L, Ogilvie L, Khajehzadehshoushtar S, Gandhi S, Garibotti M, Thuhan A, et al.
Mol Metab
. 2024 Jun;
86:101976.
PMID: 38925248
Objectives: A high proportion of women with advanced epithelial ovarian cancer (EOC) experience weakness and cachexia. This relationship is associated with increased morbidity and mortality. EOC is the most lethal...
8.
Martin G, Al-Sajee D, Gingrich M, Chattha R, Akcan M, Monaco C, et al.
Biochem Cell Biol
. 2024 Jun;
102(5):373-384.
PMID: 38843556
Altered mitochondrial structure and function are implicated in the functional decline of skeletal muscle. Numerous cytoskeletal proteins are known to affect mitochondrial homeostasis, but this complex network is still being...
9.
Rebalka I, Noguchi K, Bulyovsky K, Badour M, Juracic E, Barrett K, et al.
PLoS One
. 2024 May;
19(5):e0303448.
PMID: 38776307
Introduction: Individuals with type 1 diabetes (T1D) experience a complex set of alterations to skeletal muscle metabolic, neuromuscular, and vascular health; collectively referred to as diabetic myopathy. While the full...
10.
Delfinis L, Ogilvie L, Khajehzadehshoushtar S, Gandhi S, Garibotti M, Thuhan A, et al.
bioRxiv
. 2024 Apr;
PMID: 38645227
Objectives: A high proportion of women with advanced epithelial ovarian cancer (EOC) experience weakness and cachexia. This relationship is associated with increased morbidity and mortality. EOC is the most lethal...